Stock SCICLONE PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News SciClone Pharmaceuticals, Inc.

Equities

US80862K1043

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone
PR
SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma
PR
SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
PR
SciClone Pharmaceuticals : Reports Second Quarter 2017 Financial Results
PR
Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information
BU
SCICLONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SciClone Pharmaceuticals, Inc.
PR
Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information
BU
SciClone Pharmaceuticals : Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital
PU
SciClone Pharmaceuticals : Reports First Quarter 2017 Financial Results
PR
SciClone Pharmaceuticals : To Report First Quarter 2017 Financial Results On May 10, 2017
PR
SciClone Pharmaceuticals : To Present At Needham Healthcare Conference On April 4, 2017
PR
SciClone Pharmaceuticals : How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma
PR
SciClone Pharmaceuticals : Reports 2016 Financial Results And 2017 Outlook
PR
SciClone Pharmaceuticals : To Report Fourth Quarter And Full Year 2016 Financial Results On March 6, 2017
PR
SciClone Pharmaceuticals : Healthcare Stocks Under Scanner -- Aerie Pharma, GW Pharma, Retrophin, and SciClone Pharma
PR
SciClone Pharmaceuticals : To Present At BIO CEO & Investor Conference On February 13, 2017
PU
SciClone Pharmaceuticals : To Present At BIO CEO & Investor Conference On February 13, 2017
PR
SciClone Pharmaceuticals : Research Reports Initiation on Drug Makers Stocks -- Amphastar Pharma, United Therapeutics, MEI Pharma, and SciClone Pharma
PR
SciClone Pharmaceuticals : Confirms Receipt Of Unsolicited Proposal From GL Capital And ABG Management
PR
SciClone Pharmaceuticals : Reports Third Quarter 2016 Financial Results
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News SciClone Pharmaceuticals, Inc.